It has been reported that the lncRNA MARCKSL1-2 (MARCKSL1-transcript variant 2, NR_052852.1) promoted tumor progression by regulating epithelial–mesenchymal transition [117], thereby supporting the prognostic and therapeutic value of this lncRNA. This evidence concerns the gene MARCKSL1 and neoplasm.